Tanaka K, Koseki M, Kato H, Miyashita K, Okada T, Kanno K, Saga A, Chang J, Omatsu T, Inui H, Ohama T, Nishida M, Yamashita S, Sakata Y (2022) <br />Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia<br /><i>J Atheroscler Thromb</i> <br /><br />Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N (2019) <br />Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice<br /><i>European Journal of Pharmacology</i> <br /><br />Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger AB (2018) <br />Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes<br /><i>Oncoimmunology</i> <b>7</b>: e1412909<br /><br />Kurozumi A, Okada Y, Arao T, Kobayashi T, Masuda D, Yamashita S, Tanaka Y (2018) <br />Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients<br /><i>J Diabetes Investig</i> <b>9</b>: 360<br /><br />Dimitriou PS, Denesyuk AI, Takahashi S, Yamashita S, Johnson MS, Nakayama T, Denessiouk K (2017) <br />Alpha/beta-hydrolases: A unique structural motif coordinates catalytic acid residue in 40 protein fold families<br /><i>Proteins</i> <b>85</b>: 1845<br /><br />Hirano T, Yamashita S, Takahashi M, Hashimoto H, Mori Y, Goto M (2016) <br />Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits<br /><i>Metabolism</i> <b>65</b>: 893<br /><br />Kuroda M, Holleboom AG, Stroes ES, Asada S, Aoyagi Y, Kamata K, Yamashita S, Ishibashi S, Saito Y, Bujo H (2014) <br />Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency<br /><i>Arterioscler Thromb Vasc Biol</i> <b>34</b>: 1756<br /><br />Ohara K, Unno H, Oshima Y, Hosoya M, Fujino N, Hirooka K, Takahashi S, Yamashita S, Kusunoki M, Nakayama T (2014) <br />Structural Insights into the Low pH Adaptation of a Unique Carboxylesterase from Ferroplasma: Altering the pH optima of two carboxylesterases<br /><i>Journal of Biological Chemistry</i> <b>289</b>: 24499<br /><br />Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N (2012) <br />Diagnosis and management of type I and type V hyperlipoproteinemia<br /><i>J Atheroscler Thromb</i> <b>19</b>: 1<br /><br />Kotoh K, Fukushima M, Horikawa Y, Yamashita S, Kohjima M, Nakamuta M, Enjoji M (2012) <br />Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis<br /><i>Exp Ther Med</i> <b>3</b>: 72<br /><br />Kato N, Oka M, Murase T, Yoshida M, Sakairi M, Yamashita S, Yasuda Y, Yoshikawa A, Hayashi Y, Makino M, Takeda M, Mirensha Y, Kakigami T (2011) <br />Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methyl pyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor<br /><i>Bioorganic & Medicinal Chemistry</i> <b>19</b>: 7221<br /><br />Kato N, Oka M, Murase T, Yoshida M, Sakairi M, Yakufu M, Yamashita S, Yasuda Y, Yoshikawa A, Hayashi Y, Shirai M, Mizuno Y, Takeuchi M, Makino M, Takeda M, Kakigami T (2011) <br />Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors<br /><i>Org Med Chem Lett</i> <b>1</b>: 7<br /><br />Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, Shimizugawa T, Ando Y, Koishi R, Kohama T, Sakai N, Kotani K, Komuro R, Ishida T, Hirata K, Yamashita S, Furukawa H, Shimomura I (2007) <br />Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase<br /><i>Arterioscler Thromb Vasc Biol</i> <b>27</b>: 366<br /><br />Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T (2004) <br />Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996<br /><i>J Atheroscler Thromb</i> <b>11</b>: 131<br /><br />Saika Y, Sakai N, Takahashi M, Maruyama T, Kihara S, Ouchi N, Ishigami M, Hiraoka H, Nakamura T, Yamashita S, Matsuzawa Y (2003) <br />Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis<br /><i>European Journal of Clinical Investigation</i> <b>33</b>: 216<br /><br />Toyoda T, Sugimoto H, Yamashita S (1999) <br />Sequence, expression in Escherichia coli, and characterization of lysophospholipase II<br /><i>Biochimica & Biophysica Acta</i> <b>1437</b>: 182<br /><br />Sugimoto H, Hayashi H, Yamashita S (1996) <br />Purification, cDNA cloning, and regulation of lysophospholipase from rat liver<br /><i>Journal of Biological Chemistry</i> <b>271</b>: 7705<br /><br />Endoh M, Yamashita S, Taira N (1982) <br />Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>221</b>: 775<br /><br />Endoh M, Yamashita S (1981) <br />Differential responses to carbachol, sodium nitroprusside and 8-bromo-guanosine 3',5'-monophosphate of canine atrial and ventricular muscle<br /><i>British Journal of Pharmacology</i> <b>73</b>: 393<br /><br />Endoh M, Yamashita S (1980) <br />Adenosine antagonizes the positive inotropic action mediated via beta-, but not alpha-adrenoceptors in the rabbit papillary muscle<br /><i>European Journal of Pharmacology</i> <b>65</b>: 445<br /><br />